Wereport influenza-induced rhabodmyolysis and congestive heart failure after high-dose therapy and hematopoietic stem cell transplantation for malignant lymphoma. Four months after autologous peripheral blood stem cell transplantation for the treatment of malignant lymphoma, a 65-year-old Japanese man developed acute con-
Introduction
Community-acquired respiratory virus infections are an important cause of morbidity and mortality after allogeneic or autologous hematopoietic stem cell transplantation (HSCT). These pathogens include respiratory syncytial virus (RSV), influenza virus, picornavirus, parainfluenza virus, and adenovirus (1). There are a limited number of antiviral drugs against them. MB 23 U/Z), myoglobin 980 ng/ml (<90 ng/ml), and aldolase 12.7 IU/Z (1.7-5.7 U/Z). The urine level of myoglobin was elevated at 760 ng/ml (<10 ng/ml).
The patient did not complain of myalgia or muscle weakness, and denied alcohol drinking, drug abuse, trauma, excessive exercise, or convulsion. Thus we estimated that rhabdomyosis and congestive heart failure were induced by influenza A virus infection. To prevent acute renal failure, the patient was given forced diuresis and urine alkalinization. Heart failure and respiratory status were improved gradually, and he was extubated on the third hospital day (Fig. 2) . Abnormal shadows on The present patient had two episodes of congestive heart failure within 3 months after autologous PBSCT. The cumulative cardiotoxicities of CHOP and high-dose chemotherapy might play a some role in his congestive heart failure. In the first episode, we could not identify specific causes. In the second episode, our patient had influenza A infection-Nozoe et al induced rhabdomyolysis and congestive heart failure. Early treatment with a neuraminidase inhibitor seemed to be effective with his prompt clinical improvement. Johny et al described a successful treatment with the neuranimidase inhibitor, zanamivir, in seven patients with influenza post allograft (3). However, the natural history of influenza infection post HSCT is highly variable, and it is difficult to determ ine the real efficacy of this anti-viral specific therapy. Rhabdomyolysis in our patient was cured without deterioration of his renal function. Early recognition of this rare complication of influenza and vigorous treatment including forced diuresis and urine alkalinization might have contributed to the good treatment outcome. In conclusion, we present a case of influenza-induced rhabdomyolysis and congestive heart failure following autologous PBSCT for malignant lymphoma. Early treatment with a neuranimidase inhibitor succeeded in producing the good treatment outcome. The role of neuranimidase inhibitors in HSCT patients developing influenza infection warrants further investigation. 
